Press Releases
The italian pharmaceutical industry is the leader in Europe thanks to technology and innovation
Life Science industry represents an excellence of our country: Italy is one of the leading pharmaceutical producers in the European Union, thanks to investments in innovation of the entire supply chain. Pharmintech, the event organized by...
Press Releases
The Advanced Therapies Commercialisation Congress comes to Amsterdam on 2-3 October 2018
The Advanced Therapies Commercialisation Congress is a collaborative, multi-stakeholder meeting for exchanging views and exploring business approaches for the evolving ATMP segment. This congress convenes industry executives, public policy makers, academia and other professionals in the...
Press Releases
Record-breaking MEDICAL FAIR ASIA: The comprehensive sourcing and knowledge sharing platform
This year, MEDICAL FAIR ASIA will stage its largest edition to date, with over 1,000 exhibitors including 24 country groups, over 10,000 medical and healthcare products, as well as the special zones of - Community Care Pavilion, Start-Up Park...
Press Releases
New Cancer Target Identified for Albumin Enabled Anti-Cancer Therapeutics
Aarhus University's Interdisciplinary Nanoscience Center (iNANO) and Albumedix Ltd. (‘Albumedix’) have entered into a strategic research collaboration to evaluate the transport properties of albumin for site-selective drug delivery into disease cells to ensure more efficient and safer treatment for...
Press Releases
Plasticell leads gene therapy manufacturing consortium with Great Ormond Street Hospital and UCL Institute of Child Health
Plasticell, a developer of stem cell technologies and therapies, has announced it is leading a consortium of pioneering gene therapy groups at UCL’s Institute of Child Health (ICH) and Great Ormond Street Hospital (GOSH) to develop advanced technologies for...
Press Releases
CASI Pharmaceuticals Enters Strategic Partnering And Contract Manufacturing Agreement With Yiling Wanzhou International Pharmaceuticals For Entecavir And Cilostazol
CASI Pharmaceuticals, Inc , a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innovative therapeutics to patients in the U.S., China and throughout the world, announces a strategic and long-term manufacturing agreement...
Press Releases
Processa Pharmaceuticals Receives Orphan Designation Status For PCS499 In Necrobiosis Lipoidica From The FDA
Processa Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have a high unmet medical need, announced hat the U.S. FDA has granted orphan-drug designation to its leading...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read